Nanosphere, Inc. develops, manufactures and markets a molecular diagnostics platform, the Verigene System. The Company�s nanoparticle technology provides the ability to run multiple tests simultaneously on the same sample. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System is consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Verigene System provides for multiple tests to be performed on a single platform, including both genomic and protein assays, from a single sample. The Company developed and launched a second generation Verigene System processor (the Processor SP) that handles the same processing steps as the Original Processor and incorporates sample preparation.